| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > MANAGING CRISIS; when you're too good at it |
|
Advice You - MANAGING CRISIS; when you're too good at it
When you are acclaimed for excellence during times of crisis you may not feel so good in a non-crisis e According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product nvironment. You may not shine so bright, perform so well, be quite so acclaimed. If crisis is how you ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in satisfy your personal need to be needed, to feel accomplished, to be respected, to be heard, to be noti lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ced, blah blah blah, then you will naturally seek out, create, attract, be drawn into situations that w here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ll allow you to meet this need. Your environments and relationships will be filled to the brim with on d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e crisis after another. Perhaps there’s a better way to get your need met. Perhaps there’s a way ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc o feel needed and still exist in peaceful, cooperative, and synergistic environments. It’s amazing to easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi watch the content and features of a person’s life break apart and rebuild with almost the same irrevere nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically t qualities. People change mates but the essence of the relationship is the same. People change jobs and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ and the same complaints emerge as before. People get out of debt, lose weight, move to different cities ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi and nothing really changes. It’s a scary thing. I’ve seen the inside view and it’s very scary. This ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a d?j? vu type phenomenon has left me baffled and disheartened. Here’s the deal; when we treat the sympt dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod oms, the root cause remains unaffected and it emerges again and again. Our outer lives tell the same s cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ory over and over like a broken record until we finally get it. The outer reflects the inner. The out tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen er is a symptom; the inner is the root cause. The outer is the image in the mirror; the inner is the r t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel al object. You would not stand in the mirror with the intention of washing your face and wash the refl ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ection of your face in the mirror, would you? … I didn’t think so. Well that is exactly what we are do y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ng when we focus on treating our symptoms. A fundamental place to begin transformation is by being . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de responsible for understanding your personal needs and ensuring that they are met in an appropriate con elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ext. Get your needs met appropriately and permanently and your life will be transformed for sure. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Advertising for a Car Wash Considered Have Financial Freedom - At No Risk To Yourself Influence Management - Your Fast Track to Greater Impact, Part 1
|